Sir,

Platelet-rich plasma (PRP) means "abundant platelets that are concentrated into a small volume of plasma." The role of PRP has been demonstrated recently for the treatment of patterned hair loss. The proposed mechanism of action includes proliferation of dermal papilla cells by upregulation of growth factors and by stimulation of anagen-associated angiogenesis.\[[@ref1][@ref2]\] In this prospective case series, we planned to study the effect of PRP in chronic nonresponsive cases of patterned hair loss.

Chronic nonresponsive cases of patterned hair loss, who have used minoxidil for more than 1 year, were recruited over a period of 1 year (May 2015 to June 2016). Patients with a propensity for keloid or blood coagulopathies were excluded from the study. After a baseline evaluation and photographic and dermoscopic analyses, patients were treated with PRP therapy. Global pictures were taken in every session from the lateral, front, vertex, and back views with standard camera settings. Dermoscopic analysis (Medicam, 200X USB Video Dermatoscope Camera) was repeated before each session after marking a 1 cm^2^ area, 10 cm proximal to the midpupillary line of the right eyebrow. Three sessions of PRP injections were done at 6-week interval. Follow-up analysis was done at monthly intervals for 6 months. Adjuvant treatment comprised of topical minoxidil 5% lotion 1 ml twice daily in male patients and 2% lotion 1 ml twice daily in female patients.

We prepared PRP in an automated centrifuge machine (REMI PRP centrifuge) which worked based on the double-spin technique. To prepare PRP, whole blood (20 ml) was taken from the antecubital vein using blood collection tubes containing citrate solution as anticoagulant (Vacutainer W). The first step was "light-spin" centrifugation, which separated red blood cells from the rest of the plasma (REMI PRP centrifugation tube). After the second "heavy-spin" centrifugation, platelets spun down and were separated as a pellet at the bottom of the tube from platelet-poor plasma above. Approximately 3/4^th^ of the supernatant was discarded, and the platelet-rich pellet was resuspended in the remaining plasma. PRP was activated by adding CaCl~2~ (250 μl per 1 ml of plasma), just before its injection. The resulting platelet concentration was standardized to 0.4--0.5 million/μl.

After surgical cleansing, block anesthesia with lignocaine 2% solution without adrenaline was given in supraorbital and supratemporal nerves. PRP solution of 0.2--0.3 ml per site was injected into multiple sites by Nappage technique over the affected areas of the scalp with the help of 1-ml insulin syringe. An approximate distance of 1 cm was kept between the two injections. The remaining solution was sprinkled over the scalp followed by microneedling for better penetration of the solution. Analysis of therapeutic response was done by an independent dermatologist by comparing pre- and post-treatment photographs, and improvement was graded from 0% to 100%.

A total of 54 patients of androgenetic alopecia with chronic nonresponsive disease were recruited \[[Table 1](#T1){ref-type="table"}\]. The mean age at presentation was 28 years (range: 18--44 years), and the mean duration of illness was 4.5 years (range: 1.5--8 years). A male predominance was seen with a male-to-female ratio of 49:5. According to the Norwood Classification of male pattern baldness, there were 7 patients with Type II alopecia, 17 patients with Type IV, 15 patients with Type V and VI, and 10 patients with Type VII alopecia. According to the Ludwig Classification, among women, there were three patients with Grade I alopecia and two patients with Grade II alopecia.

###### 

Therapeutic response with platelet-rich plasma therapy as assessed by independent dermatologist

  Variable                       Level         *n*          Improvement (percentage, mean±SD)   *P*
  ------------------------------ ------------- ------------ ----------------------------------- -------
  Overall                                      54           45.74±13.11                         
  Gender                         Men           49           47.94±11.54                         0.535
  Women                          5             24±5.47                                          
  \*Grade of alopecia (*n*=49)   Type VI-VII   15           38±7.74                             0.073
  Type II-V                      34            52.22±9.88                                       

SD: Standard deviation, \*Norwood--Hamilton scale

A mean improvement of 45.74%±13.11% was seen at the end of three sessions (range: 0%--80%) \[[Figure 1](#F1){ref-type="fig"}\]. This improvement was further classified as mild \<40%, moderate 40%--80%, and excellent as more than 80% improvement. Based on this photographic analysis, mild improvement was noted in 30 (55.5%) cases and moderate in 24 (44.4%). Improvement in female patients was comparatively less, 24% (0%--60%), though the number was small to draw a conclusion. Advanced grade of alopecia (Norwood--Hamilton scale VI--VII) was associated with milder improvement compared to early disease (Norwood--Hamilton Grade II--V), though, the difference was not significant (38% vs. 52.2%, *P* = 0.073). The improvement was not related to the duration of disease, age of presentation, and baseline hemoglobin levels. The improvement in hair density was attributed to increase in the thickness of hair shaft as well as increased number of hair follicles as seen on dermoscopic evaluation \[[Figure 2](#F2){ref-type="fig"}\]. A 6-month follow-up was available in 30 patients. Maximum therapeutic response was seen after 1 month of the third injection, and reversal of response was noted in 12 (40%) patients.

![Baseline (a, c, e, and g) and follow-up (b, d, f, and h) clinical photographs of patients showing response to three injections of platelet-rich plasma therapy](IJD-64-417-g001){#F1}

![Corresponding baseline (a, c, e, and g) and follow-up (b, d, f, and h) dermoscopic images showing increase in thickness and number of hair follicles](IJD-64-417-g002){#F2}

No major complications were seen during the procedure. Mild pain during the procedure and transient swelling postprocedure were seen in majority of the patients.

Although improvement in our study was similar to the recent published studies and meta-analysis, limitation of our study included the absence of control cases and relatively small sample size.\[[@ref3][@ref4][@ref5]\] We conclude that the injection of PRP has shown positive response in our case series; however, better-designed, larger, and long-term trials with placebo control are needed to confirm its effectiveness in the management of patterned hair loss.
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